Stock Forecast

  Locust Walk Acquisition Corp. ( LWAC) Stock. Should you Buy or Sell?    $ 16.98

8.18 (32.51 %)

Locust Walk Acquisition Corp. Analysis

Updated on 10-09-2022
Symbol LWAC
Price $16.98
Beta 0.000
Volume Avg. $245.29 thousand
Market Cap $383 M
52 Week Range $8.33 - $29.2

Locust Walk Acquisition Corp. opened the day at $16.98 which is +'32.51 % on yesterday's close. Locust Walk Acquisition Corp. has a 52 week high of $29.2 and 52 week low of $8.33, which is a difference of $20.87. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $383 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Locust Walk Acquisition Corp. for $383 M, it would take 15 years to get your money back. Locust Walk Acquisition Corp. are in the Shell Companies space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Locust Walk Acquisition Corp. Stock Forecast - Is Locust Walk Acquisition Corp. a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreNeutral
PE ScoreSell
PB ScoreNeutral
Overall RecommendationNeutral

Growth and Value

PE Ratio 0.000
Dividend Yiel 0.000
Net Profit Margin 0.000

Valuing Locust Walk Acquisition Corp.

Price Book Value Ratio 0.000 Price To Book Ratio 0.000
Price To Sales Ratio 0.000 Price Earnings Ratio 0.000

How liquid is Locust Walk Acquisition Corp.

Current Ratio 0.000
Quick Ratio 0.000


Debt Ratio 0.000 Debt Equity Ratio 0.000
Long Term Debt To Capitalization 0.000 Total Debt To Capitalization 0.000

Latest news about Locust Walk Acquisition Corp.

LWAC Stock: eFFECTOR Therapeutics SPAC Merger News Sends Shares Skyrocketing

Locust Walk Acquisition (LWAC) stock is rocketing higher on Wednesday following news that it can move forward with the eFFECTOR Therapeutics. The post LWAC Stock: eFFECTOR Therapeutics SPAC Merger News Sends Shares Skyrocketing appeared first on InvestorPlace.

Date : 25/08/2021

Moore Kuehn Encourages FMBI, LWAC, LEGO and FORE Investors to Contact Law Firm

NEW YORK, June 21, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: First Midwest Bancorp, Inc. (NASDAQ: FMBI) First Midwest has agreed to merge with Old National Bancorp.

Date : 21/06/2021

About Locust Walk Acquisition Corp.

CEO : Mr. Christopher B. Ehrlich
Sector :
Industry : Shell Companies

Website :

Exchange : Nasdaq Global Select

Description :

Locust Walk Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

My Newsletter

Sign Up For Updates & Newsletters